Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.45 USD | -2.03% | -2.68% | -23.28% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 2.78M | Capitalization | 119M |
---|---|---|---|---|---|
Net income 2024 * | -119M | Net income 2025 * | -123M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 42.9 x |
P/E ratio 2024 * |
-0.99
x | P/E ratio 2025 * |
-0.9
x | Employees | 143 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.45% |
Latest transcript on Adicet Bio, Inc.
1 day | -2.03% | ||
1 week | -2.68% | ||
1 month | -2.68% | ||
3 months | -38.30% | ||
6 months | +22.88% | ||
Current year | -23.28% |
Managers | Title | Age | Since |
---|---|---|---|
Aya Jakobovits
FOU | Founder | 71 | 14-10-31 |
Chen Schor
CEO | Chief Executive Officer | 51 | 16-06-30 |
Brian Harvey
DFI | Director of Finance/CFO | 63 | 20-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steve Dubin
BRD | Director/Board Member | 70 | 20-09-14 |
Carl Gordon
CHM | Chairman | 59 | 15-08-14 |
Michael Kauffman
BRD | Director/Board Member | 60 | 21-11-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 1,487 M€ | +7.77% | - | |
0.00% | 9 M€ | +9.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.45 | -2.03% | 452,774 |
24-05-30 | 1.48 | +2.07% | 291,553 |
24-05-29 | 1.45 | -7.05% | 446,691 |
24-05-28 | 1.56 | +4.70% | 685,989 |
24-05-24 | 1.49 | -2.61% | 480,553 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.28% | 119M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- ACET Stock